VBI Vaccines to Present at the Canaccord Genuity 39th Annual Growth Conference

NEXT STORY
SELLAS Announces Completion of Enrollment in Randomized Phase 2 VADIS Trial of Nelipepimut-S (NPS) in Women with Ductal Carcinoma In Situ (DCIS) of the Breast
PREV STORY
Influenza Diagnostic Tests Market to hit $1.5 billion by 2025: Global Market Insights, Inc.
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Longeveron Expands Enrollment Criteria for its Phase 1 RECOVER Trial Evaluating Lomecel-B Infusion to Treat Acute Respiratory Distress Syndrome due to COVID-19 or Influenza Infection

author_avatar
NASDAQ Market News

Global Cephalosporin Drugs Market Insights & Projections to 2024 – Fifth-generation Segment is Expected to Account for the Largest Market Share During the Forecast Period

author_avatar
NASDAQ Market News

EyePoint Pharmaceuticals’ YUTIQ™ for Posterior Segment Uveitis to be Presented at the 2018 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

author_avatar
NASDAQ Market News